Home
Conditions
Triple Negative Breast Cancer

Clinical trial condition

Triple Negative Breast Cancer

Explore clinical trials studying Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

294 public trials 113 recruiting studies

Refine in advanced search Browse all conditions

Triple Negative Breast Cancer trial results

Recruiting

Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for TNBC

NCT06700382

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

De-escalation of Neoadjuvant Chemotherapy Regimens With Immunotherapy Among TNBC

NCT06692725

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers

NCT05403554

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +26 more
Locations: Institut Curie Paris, France

Hôpital Européen Georges Pompidou Paris, France

Centre Eugène Marquis Rennes, France

Gustave Roussy Villejuif, France, France

View Trial Details

Recruiting

The Role of Simvastatin in the Epithelial-Mesenchymal Transition Process of Breast Cancer

NCT05550415

Conditions: Breast Diseases, Breast Neoplasms, Chemotherapy Effect, +7 more
Locations: Dr. Cipto Mangunkusumo National Central General Hospital Jakarta Pusat, DKI Jakarta, Indonesia

View Trial Details

Recruiting

Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery

NCT06281210

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations: Istituto di Candiolo IRCCS Candiolo, Turin, Italy

European Institute of Oncology Milan, Italy

View Trial Details

Recruiting

LAG3 Expression in Triple Negative Breast Cancer

NCT06259162

Conditions: Breast Diseases, Breast Neoplasms, Immune Checkpoint Inhibitor, +6 more
Locations: Ji-Yeon Kim Seoul, South Korea

View Trial Details

Recruiting

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

NCT04282044

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +64 more
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

Stanford University Stanford, California, United States

View Trial Details

Recruiting

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

NCT05746897

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +37 more
Locations: NEXT Oncology, Dallas Dallas, Texas, United States

Next Oncology, Virginia Cancer Specialists Fairfax, Virginia, United States

View Trial Details

Recruiting

Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype

NCT05954442

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +7 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Platform

NCT05916755

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Vall d'Hebron Institute of Oncology Barcelona, Spain

View Trial Details

Triple Negative Breast Cancer

Triple Negative Breast Cancer trial results

Related conditions